Literature DB >> 6371055

Surface-mediated defense reactions. The plasma contact activation system.

R W Colman.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6371055      PMCID： PMC425145          DOI： 10.1172/JCI111326

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  56 in total

1.  Activation of plasminogen by human plasma kallikrein.

Authors:  R W Colman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

2.  Activation of Hageman factor in the nephrotic syndrome.

Authors:  L G Lange; A Carvalho; A Bagdasarian; B Lahiri; R W Colman
Journal:  Am J Med       Date:  1974-04       Impact factor: 4.965

3.  Cold promoted activation of factor VII. I. Evidence for the existence of an activator.

Authors:  H Gjonnaess
Journal:  Thromb Diath Haemorrh       Date:  1972-10-31

4.  Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys.

Authors:  A S Nies; R P Forsyth; H E Williams; K L Melmon
Journal:  Circ Res       Date:  1968-02       Impact factor: 17.367

6.  The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII.

Authors:  P N Walsh
Journal:  Br J Haematol       Date:  1972-04       Impact factor: 6.998

7.  The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease.

Authors:  J W Mason; R W Colman
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

8.  Plasma kallikrein and Hageman factor in Gram-negative bacteremia.

Authors:  J W Mason; U Kleeberg; P Dolan; R W Colman
Journal:  Ann Intern Med       Date:  1970-10       Impact factor: 25.391

9.  Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin.

Authors:  S Niewiarowski; E Bańkowski; I Rogowicka
Journal:  Thromb Diath Haemorrh       Date:  1965-11-15

10.  A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.

Authors:  A P Kaplan; A B Kay; K F Austen
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307
View more
  29 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.

Authors:  R A DeLa Cadena; R W Colman
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

Review 4.  Is prosthetic valve thrombogenicity related to design or material?

Authors:  L H Edmunds
Journal:  Tex Heart Inst J       Date:  1996

Review 5.  Hereditary angioedema in childhood: an approach to management.

Authors:  Didier G Ebo; Marjoke M Verweij; Kathleen J De Knop; Margo M Hagendorens; Chris H Bridts; Luc S De Clerck; Wim J Stevens
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

6.  Evaluation of surface-bound heparin and platelet inhibition in a centrifugal pump left ventricular assist system.

Authors:  J Musial; P Gluszko; L H Edmunds
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

7.  Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor.

Authors:  P Chien; R A Pixley; L G Stumpo; R W Colman; A D Schreiber
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitution.

Authors:  T Miyata; S Kawabata; S Iwanaga; I Takahashi; B Alving; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 9.  Managing the female patient with hereditary angioedema.

Authors:  Aleena Banerji; Marc Riedl
Journal:  Womens Health (Lond)       Date:  2016-03-15

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.